NEWS: GlycoBac develops Sf-RVN, a new Sf-rhabdovirus-free S. frugiperda cell line for recombinant protein production |
GlycoBac is currently providing Sf-RVN cells to interested parties under commercial Materials Transfer Agreements (for evaluation) and/or licensing agreements (for application) in various fields of use. |
Please contact Dr. Jarvis directly for additional information. |
Read another peer-reviewed paper published in the Elsevier journal 'Biologicals' about endogenous viral elements discovered by GlycoBac in Sf-RVN and other cell lines
|
|
Sf-RVN cells are a safer alternative to commonly used S. frugiperda cell lines. Listen to Prof. Dr. Jarvis talk about Sf-RVN cells and how they compare to Sf9 cells:
|
|
|
|
